Group One Trading
LFCR icon

Group One Trading’s Lifecore Biomedical LFCR Stock Holding History

Group One Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7K Buy
+2,998
New +$15.1K ﹤0.01% 6152
2025
Q2 		– Sell
-4,300
Closed -$29K – 8322
2025
Q1 		$30.3K Buy
+4,300
New +$26.7K ﹤0.01% 5535
2023
Q4 		– Sell
-14,996
Closed -$104K – 7819
2023
Q3 		$113K Buy
+14,996
New +$137K ﹤0.01% 4339
2018
Q1 		– Sell
-200
Closed -$2.63K – 5080
2017
Q4 		$3K Buy
200
+100
+100% +$1.26K ﹤0.01% 4646
2017
Q3 		$1K Buy
+100
New +$1.32K ﹤0.01% 4706
2016
Q3 		– Sell
-600
Closed -$6K – 4727
2016
Q2 		$6K Hold
600
– – ﹤0.01% 4229
2016
Q1 		$6K Buy
600
+100
+20% +$1.1K ﹤0.01% 4154
2015
Q4 		$6K Buy
+500
New +$6.14K ﹤0.01% 4330
2015
Q1 		– Sell
-1,500
Closed -$21K – 4978
2014
Q4 		$21K Buy
+1,500
New +$19.4K ﹤0.01% 3918
2014
Q2 		– Sell
-892
Closed -$10K – 5339
2014
Q1 		$10K Buy
+892
New +$9.79K ﹤0.01% 4577
2013
Q4 		– Sell
-1,408
Closed -$16.8K – 5382
2013
Q3 		$17K Sell
1,408
-5,475
-80% -$76.4K ﹤0.01% 4258
2013
Q2 		$91K Buy
+6,883
New +$95.2K ﹤0.01% 2909

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Group One Trading's LFCR Position: Q2 2026 in Review

Group One Trading opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 2,998 shares worth $15.7K. The stake represents ﹤0.01% of the portfolio and ranks #6152 among its holdings. This is a return to the name: Group One Trading previously reported a position in LFCR as recently as Q1 2025.

Group One Trading first reported a position in LFCR in Q2 2013 and has held it in 12 quarters since. The position peaked at $113K in Q3 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Group One Trading held 2,998 shares of Lifecore Biomedical worth $15.7K as of Q2 2026.
  • Lifecore Biomedical was a new Group One Trading position in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6152 holding.
  • Group One Trading first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 12 quarters since.
  • Group One Trading's Lifecore Biomedical position peaked at $113K in Q3 2023.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.